Attovia Therapeutics Inc (ATTO)

Attovia Therapeutics Inc recorded a single notable purchase during the past ninety days. Frazier Life Sciences XI, L.P. acquired 588,235 shares valued at approximately 9.99 million dollars on August 6, 2026. This solitary transaction represents the entirety of recent insider trading activity for the firm, occurring without any corresponding public disclosure regarding recent results financiers.
Ticker: ATTO Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 6 Aug 2026
Value US$893,281.61 | Price 465.80 | Shares 62,435 (+0.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-10 2026-08-06 B Purchase Large shareholder
62,435 +0.7%
465.80
US$893,282
62,435 +0.7% 465.80 US$893,282
2026-08-07 2026-08-06 B Purchase Large shareholder
70,710 -28.4%
424.03
US$4,955,529
70,710 -28.4% 424.03 US$4,955,529
2026-08-07 2026-08-06 B Purchase Large shareholder
43,802 -40.1%
375.36
US$254,690
43,802 -40.1% 375.36 US$254,690
2026-08-07 2026-08-06 B Purchase Large shareholder
1,000 +38.3%
17.00
US$100,000
1,000 +38.3% 17.00 US$100,000
2026-08-06 2026-08-06 B Purchase Large shareholder
1,000 +10.6%
17.00
US$100,000
1,000 +10.6% 17.00 US$100,000